Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Zika Diagnostic Could Rapidly Detect The Virus

XTALKS VITALS NEWS

Diagnostic Device

The latest research combines the RNA detection system with a CRISPR-based module to create a freeze-dried diagnostic for the Zika virus. Image: Wyss Institute at Harvard University.

Share this!

May 10, 2016 | by Sarah Massey, M.Sc.

The details of a paper-based prototype diagnostic device used to detect the Zika virus, have been published in the journal, Cell. The portable device was able to identify the virus in the blood and saliva of infected monkeys.

The Aedes mosquito is the primary vector responsible for transmitting the Zika virus to humans. Though the majority of those that become infected show only mild symptoms, the virus has been connected to cases of microcephaly in newborns, as well as other serious birth defects.

Because of the virus’ potential to compromise prenatal health and development in pregnant women that become infected with Zika, researchers are frantically trying to develop better diagnostic tests to control the spread of the outbreak. Among these researchers are James Collins, of the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston and his colleagues, who have developed a test capable of detecting small amounts of the Zika virus in multiple biological samples.

The researchers previously published the details of paper-based diagnostic utilizing sensors capable of detecting nucleic acids characteristic of Ebola and other RNA viruses. The latest research combines the RNA detection system with a CRISPR-based module to create a freeze-dried diagnostic for the Zika virus.



The test produces a colour change in the presence of the Zika virus. When the device was used to test blood and saliva samples taken from Zika-positive monkeys, the colourimetric detection was functional, even at low concentrations of the virus.

The study investigators caution that the device is only in the proof of concept stage. With the right resources however, they say the diagnostic could be ready for clinical use in just a few months.

As current diagnostics sometimes misidentify other viruses related to Zika, the researchers hope this tool could be more reliable. Because the test is portable, it could also help aid workers screen for the virus in areas that are without a centralized hospital or testing facility.

“The test's low cost and minimal equipment also means that it can be used for monitoring the spread of illnesses across large populations of people, enabling us to monitor the pathogen as an outbreak is occurring,” said Collins. “NGOs [non-governmental organizations] like the World Health Organization (WHO) can use this information to get ahead of an outbreak in order to contain it and save lives.”


Keywords: Zika Virus, Diagnostic Device, World Health Organization


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Could Genetic Markers Help Identify Patients at Risk of Opioid Overdose?

June 26, 2017 - Researchers at Erasmus University Medical Center in the Netherlands have identified 10 genes which may help healthcare providers predict which patients could respond poorly to opioid medications.

Featured In: Drug Safety News


Breastfeeding Mothers May Have Lower Risk of Heart Attack and Stroke Later in Life

June 23, 2017 - According to new research published in the Journal of the American Heart Association, women who breastfed their babies could have a lower future risk of suffering a heart attack or stroke.

Featured In: Pharmaceutical News


FDA Approves Shire’s New ADHD Drug

June 23, 2017 - No stranger to the ADHD market, Shire has announced that their new drug Mydayis (mixed salts of a single-entity amphetamine product) had been approved by the FDA.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Drug Development During the Last Week

REGISTER FOR THESE WEBINARS

Serialized? Yes. But are Products Still Being Diverted?


Quantitative Protein Profiling in FFPE to Characterize Toxicities Associated with Immune Checkpoint Inhibitors


Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model


Imaging-based Subtypes of Pancreatic Cancer


Copyright © 2016-2017 Honeycomb Worldwide Inc.